Logo.jpg
Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease
31. Mai 2023 09:15 ET | Biostage, Inc.
HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs...
Cernostics Announces Formation of Distinguished Medical Advisory Board Including Top Specialists in All Facets of Esophageal Disease
01. Juli 2019 09:00 ET | Cernostics
PITTSBURGH, PA, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cernostics, developer of next-generation cancer diagnostics and prognostics, today announced the formation of a distinguished...